文献速递糖尿病

社区健康工作者与同伴领导者主导的糖尿病自我管理教育支持干预的成本效果:底特律REACH试验预测

Cost-Effectiveness of a Diabetes Self-Management Education and Support Intervention Led by Community Health Workers and Peer Leaders: Projections From the Racial and Ethnic Approaches to Community Health Detroit Trial.
PubMed 文献 · Diabetes Care · 2021-05-06

该研究基于REACH底特律试验的222名拉丁裔2型糖尿病成人数据,模拟社区健康工作者(CHW)主导的糖尿病自我管理教育(DSME)后,同伴领导者(PL)主导的自我管理支持(DSMS)的长期成本效果。结果显示,与增强常规护理(EUC)相比,CHW+PL干预的增量成本效果比(ICER)为每获得一个质量调整生命年(QALY)28,800美元,与仅CHW相比为5,900美元;而仅CHW干预与EUC相比ICER为430,600美元/QALY。结论认为CHW+PL干预具有良好成本价值,而仅6个月CHW主导的DSME无后续支持不具成本效果。

要点

  • CHW+PL干预较EUC的ICER为28,800美元/QALY,较仅CHW为5,900美元/QALY。
  • 仅CHW干预较EUC的ICER为430,600美元/QALY,不具成本效果。
  • CHW+PL干预在敏感性分析中结果稳健。

核心结论

  • CHW+PL主导的DSME/DSMS干预与EUC相比改善了健康并提供了良好价值。
  • 无后续CHW支持的6个月CHW主导DSME干预在拉丁裔T2D成人中不具成本效果。

研究设计与样本

  • 试验随机分配222名拉丁裔T2D成人至EUC、仅CHW(6个月DSME+6个月CHW月度电话外展)或CHW+PL(6个月DSME+12个月PL每周小组会议及电话外展)。
  • 使用试验数据和验证的密歇根糖尿病模型,从医疗保健部门视角估算20年时间跨度的成本和健康结果,成本和收益均按每年3%贴现。
  • 主要结局指标为增量成本效果比(ICER)。

主要发现

  • 20年间,CHW+PL干预与EUC相比ICER为28,800美元/QALY,与仅CHW相比为5,900美元/QALY。
  • 仅CHW干预与EUC相比ICER为430,600美元/QALY。
  • 敏感性分析中,CHW+PL与EUC及仅CHW比较的结果对干预效果和成本变化稳健。

临床怎么用

  • 在拉丁裔T2D成人中,可考虑采用CHW主导DSME后接PL主导DSMS的干预模式以改善健康并具成本价值。
  • 仅提供6个月CHW主导DSME而无后续支持可能不具成本效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To simulate the long-term cost-effectiveness of a peer leader (PL)-led diabetes self-management support (DSMS) program following a structured community health worker (CHW)-led diabetes self-management education (DSME) program in reducing risks of complications in people with type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: The trial randomized 222 Latino adults with T2D to 1) enhanced usual care (EUC); 2) a CHW-led, 6-month DSME program and 6 months of CHW-delivered monthly telephone outreach (CHW only); or 3) a CHW-led, 6-month DSME program and 12 months of PL-delivered weekly group sessions with telephone outreach to those unable to attend (CHW + PL). Empirical data from the trial and the validated Michigan Model for Diabetes were used to estimate cost and health outcomes over a 20-year time horizon from a health care sector perspective, discounting both costs and benefits at 3% annually. The primary outcome measure was the incremental cost-effectiveness ratio (ICER). RESULTS: Over 20 years, the CHW + PL intervention had an ICER of $28,800 and $5,900 per quality-adjusted life-year (QALY) gained compared with the EUC and CHW-only interventions, respectively. The CHW-only intervention had an ICER of $430,600 per QALY gained compared with the EUC intervention. In sensitivity analyses, the results comparing the CHW + PL with EUC and CHW-only interventions were robust to changes in intervention effects and costs. CONCLUSIONS: The CHW + PL-led DSME/DSMS intervention improved health and provided good value compared with the EUC intervention. The 6-month CHW-led DSME intervention without further postintervention CHW support was not cost effective in Latino adults with T2D.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Ye W, Kuo S, Kieffer EC, et al. Cost-Effectiveness of a Diabetes Self-Management Education and Support Intervention Led by Community Health Workers and Peer Leaders: Projections From the Racial and Ethnic Approaches to Community Health Detroit Trial. Diabetes Care. 2021. PMID: 33958424. doi:10.2337/dc20-0307

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。